Paper · 39682017

Disease burden of biliary tract cancer in 204 countries and territories, 1990-2021: A comprehensive demographic analysis of the Global Burden of Disease Study 2021.

Sun X and 11 others. Chin Med J (Engl), 2024. Cited by 11 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Disease burden of biliary tract cancer in 204 countries and territories, 1990-2021: A comprehensive demographic analysis of the Global Burden of Disease Study 2021. Papers, record 39682017. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39682017

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Disease burden of biliary tract cancer in 204 countries and territories, 1990-2021: A comprehensive demographic analysis of the Global Burden of Disease Study 2021.; PubMed
Journal: Chin Med J (Engl); PubMed
Year: 2024; PubMed
Publication types: Journal Article; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/39682017/; PubMed
DOI: https://doi.org/10.1097/cm9.0000000000003395; PubMed
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC11706591/; PubMed
The journal: https://conductscience.org/library/journal-index/7513795; PubMed
Citations, by iCite: 11; iCite
Relative citation ratio, by iCite: 1.08, provisional; iCite
Revised in PubMed: 2025-06-02; PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Sun X	Xuheng
2	Liu J	Jiangmei
3	Zhang W	Wei
4	Wang Y	Yijun
5	Jiang Y	Yan
6	Wang L	Lijun
7	Zou Y	Yixin
8	Xiao Y	Yuxuan
9	Xiang Y	Yongbing
10	Li M	Maolan

1 to 10 of 12Source PubMed

See all 12 authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Global Burden of Disease	Major topic
Biliary Tract Neoplasms	Major topic
Disability-Adjusted Life Years	Major topic
Humans
Male
Female
Middle Aged
Aged
Adult
Incidence
Aged, 80 and over
Quality-Adjusted Life Years
Cost of Illness

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMID	Title	Journal	Year	In Papers	Source
42,984,373	Circular RNA SMAD4 coordinates with m6A-dependent IGF2BP2 to promote gallbladder cancer development.	Clin Transl Med	2026	https://conductscience.org/library/papers/42984373	PubMed
42,645,890	From Anatomical Staging to Precision Prognostication: Evolution of Gallbladder Cancer Staging Across AJCC Editions and the 2025 UICC TNM Update.	J Pers Med	2026	https://conductscience.org/library/papers/42645890	PubMed
42,605,860	Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.	Cochrane Database Syst Rev	2026	https://conductscience.org/library/papers/42605860	PubMed
42,583,602	Burden of gallbladder and biliary tract cancer (GBTC) in the middle east and North Africa (MENA) from 1990 to 2021: from the global burden of disease (GBD).	Ann Med Surg (Lond)	2026	https://conductscience.org/library/papers/42583602	PubMed
41,952,149	Spatiotemporal trends, demographic disparities, and predictions to 2040 in gastrointestinal cancer mortality in the United States.	BMC Public Health	2026	https://conductscience.org/library/papers/41952149	PubMed
41,463,187	DNMT3B Knockdown Enhances PARP Inhibitor Sensitivity in Biliary Tract Cancer Cells via Opioid Growth Factor Receptor-Mediated Homologous Recombination Impairment.	Cancers (Basel)	2025	https://conductscience.org/library/papers/41463187	PubMed
41,297,789	Burden profiles and mortality-attributable risk factors for gastrointestinal cancers: A comprehensive analysis, 1990-2021.	J Adv Res	2026	https://conductscience.org/library/papers/41297789	PubMed
41,097,631	Efficacy and Toxicity Profile of Carboplatin/Gemcitabine Chemotherapy in Locally Advanced or Metastatic Biliary Tract Cancer: A Single UK Centre Experience.	Cancers (Basel)	2025	https://conductscience.org/library/papers/41097631	PubMed
40,837,436	Global burden of cancer attributable to high BMI (1990-2031): a multidimensional analysis based on GBD and Mendelian randomization.	Front Nutr	2025	https://conductscience.org/library/papers/40837436	PubMed
40,693,603	Targeted therapies and immunotherapies for unresectable cholangiocarcinoma.	Chin Med J (Engl)	2025	https://conductscience.org/library/papers/40693603	PubMed

1 to 10 of 11

See all 11 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39682017

GET https://conductscience.org/api/papers/v1/39682017/authors

API reference For AI assistants